ABVC BioPharma, Inc.
ABVC
$0.742
-$0.1725-18.86%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.10% | 87.97% | -23.73% | -75.47% | 222.88% |
| Total Receivables | -4.24% | 41.16% | 18.47% | -34.57% | -0.08% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -9.42% | -36.84% | 57.86% | -29.35% | -3.31% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.26% | -1.59% | -4.28% | 5.75% | -3.42% |
| Total Current Assets | -1.89% | 22.02% | 8.32% | -33.56% | 17.13% |
|
|
|||||
| Total Current Assets | -1.89% | 22.02% | 8.32% | -33.56% | 17.13% |
| Net Property, Plant & Equipment | -1.14% | -1.40% | -1.38% | -0.85% | 466.10% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.72% | -0.25% | 0.31% | -40.41% | -46.48% |
| Total Assets | -1.17% | 1.20% | -0.22% | -12.65% | 78.01% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | -3.78% | 5.73% | -4.07% | -8.41% | 3.39% |
| Short-term Debt | 8.10% | 1.20% | 10.26% | -31.04% | -13.90% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.08% | 7.28% | 22.66% | 186.15% | 0.56% |
| Total Finance Division Other Current Liabilities | -28.02% | -33.73% | 76.87% | 693.33% | -79.78% |
| Total Other Current Liabilities | -28.02% | -33.73% | 76.87% | 693.33% | -79.78% |
| Total Current Liabilities | -3.56% | -1.28% | 11.82% | 10.62% | -7.10% |
|
|
|||||
| Total Current Liabilities | -3.56% | -1.28% | 11.82% | 10.62% | -7.10% |
| Long-Term Debt | -- | -- | -- | -- | -49.87% |
| Short-term Debt | 8.10% | 1.20% | 10.26% | -31.04% | -13.90% |
| Capital Leases | -37.85% | -28.10% | -21.91% | -19.66% | -16.73% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -7.22% | 27.65% | 0.00% | 280.70% | 0.00% |
| Total Liabilities | -4.73% | -2.41% | 9.62% | -15.52% | -22.27% |
|
|
|||||
| Common Stock & APIC | 0.26% | 1.23% | 4.11% | 2.45% | 18.49% |
| Retained Earnings | -0.27% | -1.46% | -6.01% | -4.99% | -5.62% |
| Treasury Stock & Other | 0.30% | 5.16% | -0.66% | 4.55% | 2.23% |
| Total Common Equity | 0.78% | 6.43% | -7.11% | -7.82% | 2,499.13% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 0.78% | 6.43% | -7.11% | -7.82% | 2,499.13% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 18.51% | -52.47% | -18.67% | -571.28% | -411.38% |
| Total Equity | 1.93% | 4.56% | -7.92% | -10.27% | 2,569.10% |
|
|
|||||
